Cuban Scientists Continue Fight the Covid-19

Spread the love

Havana, Sep 15 (Prensa Latina) Cuban scientists continue today with the development of diagnostic methods and vaccine candidates of national production that will allow the country to face the SARS-CoV-2 virus pandemic, which causes Covid-19.

In this way, the Caribbean nation seeks to guarantee the necessary technological sovereignty and independence from imports, the Finlay Institute states in its Twitter social network account.

Specialists from the Finlay Institute, the Business Group of the Biotechnological and Pharmaceutical Industries of Cuba, as well as from the centers of Immunoassay and Genetic Engineering and Biotechnology met this Tuesday with this premise.

Data from the Elisa type diagnostic system developed in this country, which is based on SUMA technology (UltraMicroanalytic System), to detect antibodies generated by the new coronavirus, were analyzed during the meeting.

In this sense, it is important to highlight the Umelisa SARS COV-2 IgG system, a diagnostics system created by the Immunoassay Center since last May, which allows testing a larger number of people in order to detect and identify the positives in a timely manner, isolate them and treat them.

The specialists also focused on the progress of the analytical systems for different controls of Cuban vaccines in development.

On August 24th, the initial phase of Soberana 01’s human clinical trials began, the first Cuban vaccine candidate against Covid-19, developed in three months, and whose complete results will be available at the beginning of next year.

The study is currently in the phases I and II, of security and immune response, respectively, which should conclude in November, and in case of being positive, they will allow making an effectiveness evaluation (phase III).

At the end of August, it was announced that the country is working on a second vaccine candidate against the disease, which could start its clinical trials in October.

The director of the Finlay Institute, Vicente Vérez, said that the efficacy of this new immunizer is giving very interesting responses.

During an interview with the TV station Telesur, Vérez stated that the Cuban experts’ greatest dream is to have the whole population of the country as the first one vaccinated in the world against Covid-19.

”It is a purpose that we are trying to achieve with a great sense of solidarity, because Soberana 01 will be shared with the rest of the world, and we will work so that other millions of people in friendly countries also receive it,” he said.

Since the first cases in Cuba were diagnosed on March 11, this country has accumulated 500,285 tests performed throughout the national territory, of which 4,803 were positive.

A total of 108 people died from complications associated with the disease and 4,119 have recovered.

(Taken from PL)

Leave a Reply

Your email address will not be published. Required fields are marked *